Alzheimer; News from the web:
See the story in our link for today to find out where we got that name “Alzheimer”
Read all about it HERE
Alzheimer; News from the web:
See the story in our link for today to find out where we got that name “Alzheimer”
Read all about it HERE
Alzheimer; News from the web:
Alzheimer’s disease affects some 5 million people in the United States, and as the population ages, doctors estimate those affected will more than double by 2050.
A new drug might offer new hope, WOWT reported.
Read all about it HERE
Alzheimer; News from the web:
The Alzheimer’s Association recommends family members look for symptoms such as confusion with time and place, and completing familiar tasks.
Read all about it HERE
Alzheimer; News from the web:
In a new study in JAMA Neurology, a team of neuroscientists at Mayo Clinic in Florida led by Melissa Murray, Ph.D., examined a key region of the brain and found that patterns of Alzheimer’s-related damage differed by subtype and age of onset.
The researchers say these observations could have important treatment implications.
Read all about it HERE
Alzheimer; News from the web:
Despite many promising leads, more than 120 drug treatments for Alzheimer’s disease have failed. But Cambridge-based biotech company Biogen revived hope on Tuesday with its announcement that it would seek Food and Drug Administration approval for a drug it abandoned earlier this year.
Read all about it HERE
Alzheimer; News from the web:
The biotech world went into a full-on frenzy Tuesday when drug giant Biogen dropped this whopper: The company is reviving its Alzheimer’s drug hopeful, aducanumab, after leaving it for dead all the way back in March. In fact, it’s marching forward with a Food and Drug Administration (FDA) application to approve the drug for certain patients facing cognitive decline.
Read all about it HERE